CIK 0001799448 · Non-accelerated filer<br>Smaller reporting company
Aligos Therapeutics, Inc.
Sign in to watch- Ticker
- ALGS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (800) 466-6059
- Business address
- ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-25 | Preston Heather Director | Grant or award · Stock Option (Right to Buy) | +5,860 | 5,860 | ||
| 2026-06-25 | Chavez Margarita Director | Grant or award · Stock Option (Right to Buy) | +5,860 | 5,860 | ||
| 2026-06-25 | Martell Bridget A Director | Grant or award · Stock Option (Right to Buy) | +5,860 | 5,860 | ||
| 2026-06-25 | Scopa James Paul Director | Grant or award · Stock Option (Right to Buy) | +5,860 | 5,860 | ||
| 2026-06-25 | Nuechterlein Carole Director | Grant or award · Stock Option (Right to Buy) | +5,860 | 5,860 | ||
| 2026-06-25 | Hirth Peter Director | Grant or award · Stock Option (Right to Buy) | +5,860 | 5,860 | ||
| 2026-03-09 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +23,310 | 23,310 | ||
| 2026-03-09 | Aneja Nikhil Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +9,450 | 9,450 | ||
| 2026-03-09 | Calhoun Lesley Ann See Remarks | Grant or award · Stock Option (Right to Buy) | +37,485 | 37,485 | ||
| 2026-03-09 | BLATT LAWRENCE President and CEO | Grant or award · Stock Option (Right to Buy) | +105,840 | 105,840 | ||
| 2025-07-16 | BLATT LAWRENCE President and CEO | Grant or award · Stock Option (Right to Buy) | +179,800 | 179,800 | ||
| 2025-07-16 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2025-07-16 | Calhoun Lesley Ann See Remarks | Grant or award · Stock Option (Right to Buy) | +40,185 | 40,185 | ||
| 2025-06-25 | Nuechterlein Carole Director | Grant or award · Stock Option (Right to Buy) | +5,860 | 5,860 | ||
| 2025-06-25 | Scopa James Paul Director | Grant or award · Stock Option (Right to Buy) | +5,860 | 5,860 | ||
| 2025-06-25 | Hirth Peter Director | Grant or award · Stock Option (Right to Buy) | +5,860 | 5,860 | ||
| 2025-06-25 | Preston Heather Director | Grant or award · Stock Option (Right to Buy) | +5,860 | 5,860 | ||
| 2025-06-25 | Chavez Margarita Director | Grant or award · Stock Option (Right to Buy) | +5,860 | 5,860 | ||
| 2025-06-25 | Martell Bridget A Director | Grant or award · Stock Option (Right to Buy) | +5,860 | 5,860 | ||
| 2025-02-28 | BLATT LAWRENCE President and CEO | Grant or award · Stock Option (Right to Buy) | +140,103 | 140,103 |
Page 1 of 12 · 238 trades